BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12173338)

  • 1. Molecular markers of prognosis in astrocytic tumors.
    Rasheed A; Herndon JE; Stenzel TT; Raetz JG; Kendelhardt J; Friedman HS; Friedman AH; Bigner DD; Bigner SH; McLendon RE
    Cancer; 2002 May; 94(10):2688-97. PubMed ID: 12173338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
    Ohgaki H; Kleihues P
    J Neuropathol Exp Neurol; 2005 Jun; 64(6):479-89. PubMed ID: 15977639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.
    Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K
    Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.
    Bigner SH; Matthews MR; Rasheed BK; Wiltshire RN; Friedman HS; Friedman AH; Stenzel TT; Dawes DM; McLendon RE; Bigner DD
    Am J Pathol; 1999 Aug; 155(2):375-86. PubMed ID: 10433931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity of microsatellite loci on chromosome 9p in astrocytic tumors and its prognostic implications.
    Maruno M; Yoshimine T; Muhammad AK; Tokiyoshi K; Hayakawa T
    J Neurooncol; 1996 Oct; 30(1):19-24. PubMed ID: 8864999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
    Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granular cell astrocytomas show a high frequency of allelic loss but are not a genetically defined subset.
    Castellano-Sanchez AA; Ohgaki H; Yokoo H; Scheithauer BW; Burger PC; Hamilton RL; Finkelstein SD; Brat DJ
    Brain Pathol; 2003 Apr; 13(2):185-94. PubMed ID: 12744472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
    Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
    Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the TP53 gene in human gliomas.
    Rasheed BK; McLendon RE; Herndon JE; Friedman HS; Friedman AH; Bigner DD; Bigner SH
    Cancer Res; 1994 Mar; 54(5):1324-30. PubMed ID: 8118823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
    Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H
    Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and pathologic analysis of astrocytic tumors with loss of heterozygosity on chromosome 10q].
    Zhou FA; Li JZ; Ma YQ; Miao N; Liu X; Li XX; Zhang W
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):618-21. PubMed ID: 23157831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of molecular alterations in microdissected archival gliomas.
    Walker C; Joyce KA; Thompson-Hehir J; Davies MP; Gibbs FE; Halliwell N; Lloyd BH; Machell Y; Roebuck MM; Salisbury J; Sibson DR; Du Plessis D; Broome J; Rossi ML
    Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolution.
    Wooten EC; Fults D; Duggirala R; Williams K; Kyritsis AP; Bondy ML; Levin VA; O'Connell P
    Neuro Oncol; 1999 Jul; 1(3):169-76. PubMed ID: 11550311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of loss of heterozygosity around three candidate tumor suppressor genes on chromosome 10q in astrocytomas.
    Terada K; Tamiya T; Daido S; Kambara H; Tanaka H; Ono Y; Matsumoto K; Ito S; Ouchida M; Ohmoto T; Shimizu K
    J Neurooncol; 2002 Jun; 58(2):107-14. PubMed ID: 12164681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathogenesis of malignant gliomas.
    Rasheed BK; Wiltshire RN; Bigner SH; Bigner DD
    Curr Opin Oncol; 1999 May; 11(3):162-7. PubMed ID: 10328589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic sub-types of human malignant astrocytoma correlate with survival.
    Leenstra S; Oskam NT; Bijleveld EH; Bosch DA; Troost D; Hulsebos TJ
    Int J Cancer; 1998 Apr; 79(2):159-65. PubMed ID: 9583731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survival.
    Tada K; Shiraishi S; Kamiryo T; Nakamura H; Hirano H; Kuratsu J; Kochi M; Saya H; Ushio Y
    J Neurosurg; 2001 Oct; 95(4):651-9. PubMed ID: 11596960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
    Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M
    Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
    Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.